Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial

Overview of attention for article published in Diabetes Research & Clinical Practice, September 2025

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,021 followers.

RT @RodolfoJGalindo: Wondering which GLP1a for CV prevention in T2D but with moderate cardiovascular risk (not tested in RCTs). @RozalinaM…

Wondering which GLP1a for CV prevention in T2D but with moderate cardiovascular risk (not tested in RCTs). @RozalinaMD @MarylandMed @umiamimedicine https://t.co/EmP8qfUyCo

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.